| Metric | შპს ბიოპოლუსი | სს ბიოფარმი |
|---|---|---|
| Growth | ||
| Revenue | ₾6.5m₾12.8m | ₾10.1m₾9.7m |
| Revenue growth | -49.1% | 4.8% |
| Profitability | ||
| EBITDA | ₾1.9m₾3.4m | -₾847k-₾427k |
| EBITDA margin | 29.2%26.7% | -8.3%-4.4% |
| Net profit | ₾1.5m₾3.4m | -₾1.3m-₾1.1m |
| Net margin | 23.6%26.3% | -12.6%-11.5% |
| Balance sheet | ||
| Total assets | ₾14.7m₾13.6m | ₾19.1m₾18.5m |
| Total equity | ₾11.7m₾10.2m | ₾18.2m₾17.1m |
| ROE | 13.1%33.0% | -7.0%-6.5% |